We further validated this using ovarian cancer specimens and immunohistochemistry and found that ST14 is highly expressed in ovarian cancer, specifically in advanced stages and poorly differentiation groups, and is an independent risk factor for prognosis. This evidence concerns the gene ST14 and ovarian cancer.